The scope of endometrial polyp's therapy and secondary prevention

• Galina E. Chernukha
• Ilya A. Ivanov
• Madina R. Dumanovskaya

Abstract

The aim of the study was to conduct a systematic analysis of current literature on existing approaches to the endometrial polyps's (EP) treatment and their impact on the risk of relapse.

Material and methods. The review includes articles by foreign and Russian authors published in the journals of Pubmed, Cochrane, Web of Science, MEDLINE, and Google Scholar over the past 10 years.

Results. The analysis contains the scope of EP's treatment approaches, their advantages and disadvantages, including wait-and-see tactics. A comparative analysis of data may indicate the insufficient relationship between different surgical techniques and EP's recurrence rate.

Conclusion. It was determined that the existing methods of polypectomy cannot guarantee a stable therapeutic effect. From this point of view, the development of new pathogenetically oriented methods of treatment and prevention of EP is urgent.

Keywords:endometrial polyps, treatment, hysteroscopy, reccurence, LNG-IUD

References

1. Clark T.J., Stevenson H. Endometrial Polyps and Abnormal Uterine Bleeding (AUB-P) - what is the relationship; how are they diagnosed and how are they treated? Best Pract Res Clin Obstet Gynaecol. 2017; 40: 89-104.

2. Tanos V., Berry K.E., Seikkula J., Abi Raad E., Stavroulis A., Sleiman Z., et al. The management of polyps in female reproductive organs. Int J Surg. 2017; 43: 7-16.

3. Capmas P., Pourcelot A.G., Giral E., Fedida D., Fernandez H. Office hysteroscopy: a report of 2402 cases. J Gynecol Obstet Biol Reprod (Paris). 2016; 45 (5): 445-50.

4. Chernukha G.E., Asaturova A.V., Ivanov I.A., Dumanovskaya M.R. Endometrial lesion's pattern in different age groups. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2018; (8): 129-34. (in Russian).

5. Paradisi R., Rossi S., Scifo M.C., Dall' O.F., et al. Recurrence of endometrial polyps. Gynecol Obstet Invest. 2014; 78: 26-32.

6. Kanthi J., Mangala J., Remadevi C., Sumathy S. Clinical study of endometrial polyp and role of diagnostic hysteroscopy and blind avulsion of polyp. J Clin Diagn Res (JCDR). 2016; 10 (6): QC01-4.

7. Henriquez D.D., van Dongen H., Wolterbeek R., Jansen F.W. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal. J Minim Invasive Gynecol. 2007; 14: 59-63.

8. AlHilli M.M., Nixon K.E., Hopkins M.R., Weaver A.L., et al. Longterm outcomes after intrauterine morcellation vs hysteroscopic resection of endometrial polyps. J Minim Invasive Gynecol. 2013; 20 (2): 215-21.

9. Yang J.-H., Chen C.-D., Chen S.-U., Yang Y.-S., Chen M.-J. Factors influencing the recurrence potential of benign endometrial polyps after hysteroscopic polypectomy. PLoS One. 2015; 10 (12): e0144857.

10. Nijkang N.P., Anderson L., Markham R., Manconi F. Endometrial polyps: pathogenesis, sequelae and treatment. SAGE Open Med. 2019; 7: 2050312119848247.

11. Annan J.J., Aquilina J., Ball E. The management of endometrial polyps in the 21st century. Obstet Gynaecol. 2012; 14: 33-38.

12. Marnach M.L., Laughlin-Tommaso S.K. Evaluation and management of abnormal uterine bleeding. Mayo Clin Proc. 2019; 94 (2): 326-35.

13. Endometrial Polyps. National Guideline approved by The Norwegian Society of Obstetrics and Gynecology. Nordic Federation of Societies of Obstetrics and Gynecology, 2015.

14. Wolfman W., et al. Asymptomatic endometrial thickening. In: SOGC Clinical Practice Guideline No. 249. May 2018.

15. DeWaay D.J., Syrop C.H., Nygaard I.E., Davis W.A., Van Voorhis B.J. Natural history of uterine polyps and leiomyomata. Obstet Gynecol. 2002; 100: 3-7.

16. Lieng M., Istre O., Sandvik L., Qvigstad E. Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study. J Minim Invasive Gynecol. 2009; 16: 465-71.

17. American Association of Gynecologic Laparoscopists. AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps. J Minim Invasive Gynecol. 2012; 19 (1): 3-10.

18. Salim S., Won H., Nesbitt-Hawes E., Campbell N., Abbott J. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol. 2011; 18 (5): 569-81.

19. Fadl S.A., Sabry A.S., Hippe D.S., Al-Obaidli A., et al. Diagnosing polyps on transvaginal sonography: is sonohysterography always necessary? Ultrasound Q. 2018; 34 (4): 272-7.

20. Venturella R., Miele G., Cefall K., Lico D., et al. Subcutaneous progesterone for endometrial polyps in premenopausal women: a preliminary retrospective analysis. J Minim Invasive Gynecol. 2019; 26 (1): 143-7.

21. Chowdary P., Maher P., Ma T., Newman M., Ellett L., Readman E. The role of the Mirena intrauterine device in the management of endometrial polyps: a pilot study. J Minim Invasive Gynecol. 2019; 26 (7): 1297-302.

22. Sattarov S.N., Kogan E.A., Sarkisov S.E., et al. Molecular mechanisms of the pathogenesis of postmenopausal endometrial polyps. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2013; (6): 17-22. (in Russian)

23. Preutthipan S., Herabutya Y. Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women. Fertil Steril. 2005; 83 (3): 705-99.

24. Gao W., Zhang L., Li W., Li J., Wang W., et al. Three-year follow-up results of polypectomy with endometrial ablation in the management of endometrial polyps associated with tamoxifen in Chinese women. Eur J Obstet Gynecol Reprod Biol. 2012; 161: 62-5.

25. Nappi L., Sorrentino F., Angioni S., Pontis A., et al. Feasibility of hysteroscopic endometrial polypectomy using a new dual wavelengths laser system (DWLS): preliminary results of a pilot study. Arch Gynecol Obstet. 2017; 295 (1): 3-7.

26. Lysenko O.V. Endometrial adenocarcinoma and endometrial polyps in postmenopausal period: cytokine balance, SFAS-ligand production and therapy. Vestnik VSMU. Akusherstvo i ginekologiya [Bulletin of VSMU. Obstetrics and Gynecology]. 2014; 13 (3): 85-91. (in Russian).

27. Bakour S., Gupta J., Khan K. Risk factors associated with endometrial polyps in abnormal uterine bleeding. Int J Gynaecol Obstet. 2002; 76: 165-8.

28. Wan Y.L., Holland C. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review. Climacteric. 2011; 14: 622-32.

29. Dominick S., Hickey M., Chin J., Su H.I. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Syst Rev. 2015; 12: CD007245.

30. Wheeler D.T., Bristow R.E., Kurman R.J. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol. 2007; 31 (7): 988-98.

31. Gallos I.D. Predictive ability of estrogen receptor (ER), progesterone receptor (PR), COX-2, Mlh1, and Bcl-2 expressions for regression and relapse of endometrial hyperplasia treated with LNG-IUS: a prospective cohort study. Gynecol Oncol. 2013; 130 (1): 58-63.

32. Chernukha G.E., Shigoreva T.V., Mogirevskaya O.A., Silakova A.V., Kasyan V.N. Sex steroid hormone receptor expression and cell proliferation in different forms of endometrial hyperplasia. Impact of the levonorgestrel-releasing intrauterine system. Akusherstvo i ginekologiya [Obstetrics and Gynecology] 2011; (6): 64-9. (in Russian).

33. Hejmadi R.K., Chaudhri S., Ganesan R., Rollason T.P. Morphologic changes in the endometrium associated with the use of the Mirena coil: a retrospective study of 106 cases. Int J Surg Pathol. 2007; 15 (2): 148-54.

34. Guttinger A., Critchley H.O. Endometrial effects of intrauterine levonorgestrel. Contraception. 2007; 75 (6): S93-8.

35. Orbo A., Arnes M., Pettersen I., Larsen K., et al. Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system. Acta Obstet Gynecol Scand. 2010; 89 (11): 1438-46.

36. Baak J.P., Mutter G.L. EIN and WHO94. Considering the classification of endometrial hyperplasia. J Clin Pathol. 2005; 58: 1-6.

37. Vereide A.B. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol Oncol. 2003; 91 (3): 526-33.

38. Cleator S.J., Ahamed E., Coombes R.C., Palmieri C. A 2009 update on the treatment of patients with hormone receptor-positive breast cancer. Clin Breast Cancer. 2009; 9 (suppl 1): S6-17.

39. Critchley H.O., Wang H., Kelly R.W., Gebbie A.E., Glasier A.F. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod. 1998; 13 (5): 1210-7.

40. Weng M., Li L., Feng S., Xie M., Hong S. Effects of levonorgestrel-releasing intrauterine system on endometrial estrogen and aprogesterone receptors in patients with endometrial hyperplasia. Nan Fang Yi Ke Da Xue Xue Bao. 2012; 32 (9): 1350-4.

41. Chernukha G.E., Ivanov I.A., Dumanovskaya M.R. Hormonal sensitivity of endometrial polyps and the efficiency of LNG-IUD as a method of their secondary prevention. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2020; (6): 65-71. (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)